{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:15:01Z","timestamp":1791321301704,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.placenta.2014.11.003","type":"journal-article","created":{"date-parts":[[2014,11,16]],"date-time":"2014-11-16T21:30:04Z","timestamp":1416173404000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Ex\u00a0vivo model of congenital cytomegalovirus infection and new combination therapies"],"prefix":"10.1016","volume":"36","author":[{"given":"L.","family":"Mor\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5366-5063","authenticated-orcid":false,"given":"D.","family":"Andouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Labrousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-A.","family":"Calliste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Aubard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.D.","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Esclaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Ploy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.placenta.2014.11.003_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N.\u00a0Engl J Med"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.placenta.2014.11.003_bib2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jcv.2009.09.002","article-title":"Congenital cytomegalovirus (CMV) epidemiology and awareness","volume":"46","author":"Cannon","year":"2009","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.placenta.2014.11.003_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/pd.59","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome","volume":"21","author":"Enders","year":"2001","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib4","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1128\/JCM.41.4.1772-1774.2003","article-title":"Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay","volume":"41","author":"Revello","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.placenta.2014.11.003_bib5","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1093\/cid\/cit611","article-title":"Congenital cytomegalovirus infection: an obstetrician's point of view","volume":"57","author":"Soper","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.placenta.2014.11.003_bib6","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/cid\/cit629","article-title":"Congenital cytomegalovirus infection: clinical outcome","volume":"57","author":"Boppana","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.placenta.2014.11.003_bib7","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1128\/JVI.74.15.6808-6820.2000","article-title":"Human cytomegalovirus infection of placental cytotrophoblasts in\u00a0vitro and in utero: implications for transmission and pathogenesis","volume":"74","author":"Fisher","year":"2000","journal-title":"J\u00a0Virology"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib8","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1128\/JVI.72.6.4970-4979.1998","article-title":"Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts","volume":"72","author":"Hemmings","year":"1998","journal-title":"J\u00a0Virology"},{"key":"10.1016\/j.placenta.2014.11.003_bib9","first-page":"203","article-title":"Prenatal cytomegalovirus infection: epidemiology, pathology and pathogenesis","volume":"6","author":"Becroft","year":"1981","journal-title":"Perspect Pediatr Pathology"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01606887","article-title":"Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining","volume":"423","author":"Sinzger","year":"1993","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.placenta.2014.11.003_bib11","doi-asserted-by":"crossref","first-page":"e52899","DOI":"10.1371\/journal.pone.0052899","article-title":"Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes","volume":"7","author":"Hamilton","year":"2012","journal-title":"PloS One"},{"issue":"2A","key":"10.1016\/j.placenta.2014.11.003_bib12","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/0002-9343(92)90329-A","article-title":"Mechanism of action of foscarnet against viral polymerases","volume":"92","author":"Crumpacker","year":"1992","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003495-199448020-00007","article-title":"A\u00a0reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections","volume":"48","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/517002","article-title":"Ganciclovir therapy for severe cytomegalovirus infection in immunocompetent patients","volume":"25","author":"Jacobson","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.placenta.2014.11.003_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0","article-title":"Clinical uses of cidofovir","volume":"7","author":"Safrin","year":"1997","journal-title":"Rev Med Virology"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.antiviral.2012.09.010","article-title":"Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication","volume":"96","author":"Cotin","year":"2012","journal-title":"Antivir Res"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib17","doi-asserted-by":"crossref","first-page":"e20932","DOI":"10.1371\/journal.pone.0020932","article-title":"Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase\/Akt pathway","volume":"6","author":"Cheng","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1097-2765(05)00089-4","article-title":"Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine","volume":"6","author":"Walker","year":"2000","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.placenta.2014.11.003_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2005.08.002","article-title":"Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action","volume":"68","author":"Evers","year":"2005","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0091270006296765","article-title":"Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment","volume":"47","author":"Swan","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.placenta.2014.11.003_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.45.2.593-595.2001","article-title":"Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency","volume":"45","author":"Wolf","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.placenta.2014.11.003_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jmv.10277","article-title":"Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia","volume":"69","author":"Mengelle","year":"2003","journal-title":"J\u00a0Med Virology"},{"issue":"1\u20132","key":"10.1016\/j.placenta.2014.11.003_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jviromet.2006.07.019","article-title":"Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients","volume":"138","author":"Mazet-Wagner","year":"2006","journal-title":"J\u00a0Virological Methods"},{"issue":"1","key":"10.1016\/j.placenta.2014.11.003_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-3542(02)00094-3","article-title":"Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus","volume":"56","author":"Evers","year":"2002","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.34.2.373","article-title":"Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in\u00a0vitro","volume":"34","author":"Manischewitz","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.placenta.2014.11.003_bib28","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/AAC.00207-06","article-title":"Effect of cell culture conditions on the anticytomegalovirus activity of maribavir","volume":"50","author":"Chou","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"10.1016\/j.placenta.2014.11.003_bib29","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome","volume":"256","author":"Stagno","year":"1986","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.placenta.2014.11.003_bib30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/adc.66.9.1068","article-title":"Outcome of confirmed symptomatic congenital cytomegalovirus infection","volume":"66","author":"Ramsay","year":"1991","journal-title":"Archives Dis Child"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib31","first-page":"909","article-title":"In situ hybridization analysis for cytomegalovirus in chronic villitis","volume":"10","author":"Sachdev","year":"1990","journal-title":"Pediatr Pathology\/Affiliated Int Paediatr Pathology Assoc"},{"issue":"8","key":"10.1016\/j.placenta.2014.11.003_bib32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0046-8177(94)90252-6","article-title":"Detection of the human cytomegalovirus gene in placental chronic villitis by polymerase chain reaction","volume":"25","author":"Nakamura","year":"1994","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.placenta.2014.11.003_bib33","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1128\/JVI.72.9.7598-7602.1998","article-title":"Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus","volume":"72","author":"Halwachs-Baumann","year":"1998","journal-title":"J\u00a0Virology"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jmv.1077","article-title":"Complete replication of human cytomegalovirus in explants of first trimester human placenta","volume":"64","author":"Gabrielli","year":"2001","journal-title":"J\u00a0Med Virology"},{"issue":"7","key":"10.1016\/j.placenta.2014.11.003_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.placenta.2011.04.016","article-title":"Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3-dioxygenase activity","volume":"32","author":"Lopez","year":"2011","journal-title":"Placenta"},{"issue":"11","key":"10.1016\/j.placenta.2014.11.003_bib36","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/0046-8177(92)90290-J","article-title":"Cytomegalovirus infection of the human placenta: an immunocytochemical study","volume":"23","author":"Muhlemann","year":"1992","journal-title":"Hum Pathol"},{"issue":"24","key":"10.1016\/j.placenta.2014.11.003_bib37","doi-asserted-by":"crossref","first-page":"13301","DOI":"10.1128\/JVI.77.24.13301-13314.2003","article-title":"Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity","volume":"77","author":"Pereira","year":"2003","journal-title":"J\u00a0Virology"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2353\/ajpath.2006.050482","article-title":"Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis","volume":"168","author":"Maidji","year":"2006","journal-title":"Am J Pathology"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kem014","article-title":"Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase\/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes","volume":"46","author":"Xu","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2010.29807","article-title":"Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes","volume":"92","author":"Chuang","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/JVI.77.2.905-914.2003","article-title":"The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress","volume":"77","author":"Krosky","year":"2003","journal-title":"J\u00a0Virology"},{"issue":"6","key":"10.1016\/j.placenta.2014.11.003_bib42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.placenta.2014.11.003_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in\u00a0vitro and in\u00a0vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib44","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.transproceed.2013.01.082","article-title":"Maribavir use in practice for cytomegalovirus infection in French transplantation centers","volume":"45","author":"Alain","year":"2013","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.placenta.2014.11.003_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414008327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400414008327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:50:37Z","timestamp":1758909037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400414008327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0143400414008327"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2014.11.003","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex\u00a0vivo model of congenital cytomegalovirus infection and new combination therapies","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2014.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}